Drug and gene delivery to the brain: the vascular route - PubMed (original) (raw)
Review
. 2002 Nov 14;36(4):555-8.
doi: 10.1016/s0896-6273(02)01054-1.
Affiliations
- PMID: 12441045
- DOI: 10.1016/s0896-6273(02)01054-1
Free article
Review
Drug and gene delivery to the brain: the vascular route
William M Pardridge. Neuron. 2002.
Free article
Abstract
Brain drug development of either small molecule or large molecule (recombinant proteins, gene medicines) neurotherapeutics has been limited, owing to the restrictive transport properties of the brain microvasculature, which forms the blood-brain barrier (BBB) in vivo. Widespread drug delivery to the brain, while not feasible via craniotomy and intracerebral injection, is possible if the drug is delivered to brain via the transvascular route through the BBB. Novel brain drug delivery and drug targeting strategies can be developed from an understanding of the molecular and cellular biology of the brain microvascular and BBB transport processes.
Similar articles
- Molecular and cellular permeability control at the blood-brain barrier.
Gloor SM, Wachtel M, Bolliger MF, Ishihara H, Landmann R, Frei K. Gloor SM, et al. Brain Res Brain Res Rev. 2001 Oct;36(2-3):258-64. doi: 10.1016/s0165-0173(01)00102-3. Brain Res Brain Res Rev. 2001. PMID: 11690623 Review. - The blood-brain barrier: bottleneck in brain drug development.
Pardridge WM. Pardridge WM. NeuroRx. 2005 Jan;2(1):3-14. doi: 10.1602/neurorx.2.1.3. NeuroRx. 2005. PMID: 15717053 Free PMC article. Review. - Differential receptor-mediated drug targeting to the diseased brain.
Rip J, Schenk GJ, de Boer AG. Rip J, et al. Expert Opin Drug Deliv. 2009 Mar;6(3):227-37. doi: 10.1517/17425240902806383. Expert Opin Drug Deliv. 2009. PMID: 19327042 Review. - Protection against hypoxia-induced increase in blood-brain barrier permeability: role of tight junction proteins and NFkappaB.
Brown RC, Mark KS, Egleton RD, Huber JD, Burroughs AR, Davis TP. Brown RC, et al. J Cell Sci. 2003 Feb 15;116(Pt 4):693-700. doi: 10.1242/jcs.00264. J Cell Sci. 2003. PMID: 12538770 - Brain barriers: Crosstalk between complex tight junctions and adherens junctions.
Tietz S, Engelhardt B. Tietz S, et al. J Cell Biol. 2015 May 25;209(4):493-506. doi: 10.1083/jcb.201412147. J Cell Biol. 2015. PMID: 26008742 Free PMC article. Review.
Cited by
- Fatty acid-based strategy for efficient brain targeted gene delivery.
Shen J, Yu M, Meng Q, Li J, Lv Y, Lu W. Shen J, et al. Pharm Res. 2013 Oct;30(10):2573-83. doi: 10.1007/s11095-013-1056-x. Epub 2013 Apr 23. Pharm Res. 2013. PMID: 23609561 - Use of ultrasound pulses combined with Definity for targeted blood-brain barrier disruption: a feasibility study.
McDannold N, Vykhodtseva N, Hynynen K. McDannold N, et al. Ultrasound Med Biol. 2007 Apr;33(4):584-90. doi: 10.1016/j.ultrasmedbio.2006.10.004. Ultrasound Med Biol. 2007. PMID: 17337109 Free PMC article. - Modulation of intracellular Ca2+ concentration in brain microvascular endothelial cells in vitro by acoustic cavitation.
Park J, Fan Z, Kumon RE, El-Sayed ME, Deng CX. Park J, et al. Ultrasound Med Biol. 2010 Jul;36(7):1176-87. doi: 10.1016/j.ultrasmedbio.2010.04.006. Ultrasound Med Biol. 2010. PMID: 20620704 Free PMC article. - Strategies for Drug Delivery into the Brain: A Review on Adenosine Receptors Modulation for Central Nervous System Diseases Therapy.
Fernandez M, Nigro M, Travagli A, Pasquini S, Vincenzi F, Varani K, Borea PA, Merighi S, Gessi S. Fernandez M, et al. Pharmaceutics. 2023 Oct 10;15(10):2441. doi: 10.3390/pharmaceutics15102441. Pharmaceutics. 2023. PMID: 37896201 Free PMC article. Review. - Herpes simplex virus oncolytic therapy for pediatric malignancies.
Friedman GK, Pressey JG, Reddy AT, Markert JM, Gillespie GY. Friedman GK, et al. Mol Ther. 2009 Jul;17(7):1125-35. doi: 10.1038/mt.2009.73. Epub 2009 Apr 14. Mol Ther. 2009. PMID: 19367259 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical